PVP with or without microwave ablation for the treatment of painful spinal metastases from NSCLC: a retrospective case-control study
Open Access
- 3 August 2023
- journal article
- research article
- Published by Taylor & Francis in International Journal of Hyperthermia
- Vol. 40 (1) , 2241687
Abstract
To compare the clinical efficacy of percutaneous vertebroplasty (PVP) alone and microwave ablation (MWA) combined with PVP for the treatment of painful spinal metastases from non-small cell lung cancer (NSCLC). From October 2014 to October 2021, the data of 58 NSCLC patients with refractory painful spinal metastases (visual analog scale score ≥ 5) were retrospectively collected and analyzed. Patients in Group A (n = 30) and Group B (n = 28) received PVP alone and MWA combined with PVP, respectively. The primary endpoint was pain relief. The secondary endpoints were quality of life (QoL), local tumor progression (LTP), and complications. The technical success rate was 100% in both groups. Patients in both groups showed similar pain relief at 1-12 weeks, but patients in Group B still showed sustained pain relief at 24 weeks compared to those in Group A (p = 0.03). The assessment of QoL showed similar changes. LTP (33.00% vs. 7.14%, p = 0.02) and cement leakage rates (40.00% vs. 7.14%, p = 0.03) were lower in Group B. The multivariate analysis demonstrated spinal metastases with a maximum diameter ≤ 3.0 cm (p = 0.027) and MWA combined with PVP (p = 0.028) were two independent protective factors for LTP. For cement leakage, spinal metastases with vertebral body compression (p = 0.019) was an independent risk factor, while MWA combined with PVP (p = 0.042) was an independent protective factor. MWA combined with PVP for painful spinal metastases from NSCLC performed more sustained pain relief (>6 months) and ultimately improved QoL with lower LTP and cement leakage rates, compared to PVP alone.Keywords
This publication has 32 references indexed in Scilit:
- Percutaneous Vertebroplasty Relieves Pain in Cervical Spine MetastasesPain Research and Management, 2017
- Quality of life after different surgical procedures for the treatment of spinal metastases: results of a single-center prospective case seriesNeurosurgical Focus, 2017
- Reproducibility of mRECIST in assessing response to transarterial radioembolization therapy in hepatocellular carcinomaHepatology, 2015
- Clinical applications of the C-arm cone-beam CT-based 3D needle guidance system in performing percutaneous transthoracic needle biopsy of pulmonary lesionsDiagnostic and Interventional Radiology, 2014
- Microwave Thermal Ablation of Spinal Metastatic Bone TumorsJournal of Vascular and Interventional Radiology, 2014
- Comparison of external radiotherapy and percutaneous vertebroplasty for spinal metastasisAsia-Pacific Journal of Clinical Oncology, 2014
- Current Paradigms for Metastatic Spinal Disease: An Evidence-Based ReviewAnnals of Surgical Oncology, 2013
- Treatment of Bone Metastases with Microwave Thermal AblationJournal of Vascular and Interventional Radiology, 2013
- Clinical Investigations on the Spinal Osteoblastic Metastasis Treated by Combination of Percutaneous Vertebroplasty and 125 I Seeds Implantation Versus RadiotherapyCancer Biotherapy and Radiopharmaceuticals, 2013
- A prospective study of percutaneous vertebroplasty in patients with myeloma and spinal metastasesClinical Radiology, 2011